Discovery’s ‘First In Human’ Calls Much-Needed Attention To Clinical Trials – Forbes
Forbes |
Discovery's 'First In Human' Calls Much-Needed Attention To Clinical Trials
Forbes Cooper enrolled in a trial of a chimeric antigen receptor T cell (CAR-T) therapy, which involved removing T cells from his blood and engineering them to recognize and attack his cancer. This technology that has been in the spotlight lately, thanks to … |
